Apabetalone downregulates IL-6 expression in several cell types, including LPS-stimulated human macrophages [29], endothelial cells under a variety of inflammatory stimuli [16,26], and arterial expression in a murine model of atherosclerosis [29]. The gene discussed is IL6; the disease is atherosclerosis.